نتائج البحث

Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study.

• Authors : Sun CM; Centre de Recherche des Cordeliers, Paris, France.; Toulmonde M

Subjects: Antineoplastic Agents, Alkylating*/Antineoplastic Agents, Alkylating*/Antineoplastic Agents, Alkylating*/therapeutic use ; Sarcoma*/Sarcoma*/Sarcoma*/drug therapy ; Sarcoma*/Sarcoma*/Sarcoma*/pathology

• Source: Molecular cancer [Mol Cancer] 2024 Feb 19; Vol. 23 (1), pp. 37. Date of Electronic Publication: 2024 Feb 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients.

• Authors : Ducray F; INSERM, U842, Lyon, F-69372 France. ; de Reyniès A

Subjects: Oligonucleotide Array Sequence Analysis*; Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/*therapeutic use ; Glioblastoma/Glioblastoma/Glioblastoma/*drug therapy

• Source: Molecular cancer [Mol Cancer] 2010 Sep 07; Vol. 9, pp. 234. Date of Electronic Publication: 2010 Sep 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.

• Authors : Tso, Jonathan L; Yang, Shuai; Menjivar, Jimmy C

Subjects: Tumor Cells; Cultured; Humans

• Source: Molecular cancer. 14(1)

تفاصيل العنوان

Chemoresistance of glioblastoma cancer stem cells--much more complex than expected.

• Authors : Beier D; Department of Neurology, RWTH Aachen, Medical School, Pauwelsstrasse 30, 52074 Aachen, Germany.; Schulz JB

Subjects: Drug Resistance, Neoplasm*; Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/*therapeutic use ; Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*pathology

• Source: Molecular cancer [Mol Cancer] 2011 Oct 11; Vol. 10, pp. 128. Date of Electronic Publication: 2011 Oct 11.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities.

• Authors : Das A; Department of Neurology, Medical University of South Carolina, Charleston, USA. ; Banik NL

Subjects: Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/*antagonists & inhibitors ; Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/*pharmacology ; Apoptosis/Apoptosis/Apoptosis/*drug effects

• Source: Molecular cancer [Mol Cancer] 2004 Dec 08; Vol. 3 (1), pp. 36. Date of Electronic Publication: 2004 Dec 08.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.

• Authors : Lu C; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu, China.; Wei Y

Subjects: DNA Methylation* ; Drug Resistance, Neoplasm*; E2F7 Transcription Factor/E2F7 Transcription Factor/E2F7 Transcription Factor/*metabolism

• Source: Molecular cancer [Mol Cancer] 2020 Feb 10; Vol. 19 (1), pp. 28. Date of Electronic Publication: 2020 Feb 10.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

Differential chemosensitivity to antifolate drugs between RAS and BRAF melanoma cells.

• Authors : Arozarena, Imanol¹ ; Goicoechea, Ibai² ; Erice, Oihane³

• Source: Molecular Cancer. 2014, Vol. 13 Issue 1, p1-24. 24p. 1 Diagram, 5 Graphs.

تفاصيل العنوان

Chemoresistance of glioblastoma cancer stem cells - much more complex than expected.

Subjects: GLIOBLASTOMA multiforme; CANCER stem cells; DRUG therapy

• Source: Molecular Cancer; 2011, Vol. 10 Issue 1, p128-138, 11p, 1 Diagram, 1 Chart

تفاصيل العنوان

The evolving concept of liver cancer stem cells.

• Authors : Kouki Nio; Taro Yamashita; Shuichi Kaneko

Subjects: CANCER relapse; CANCER stem cells; INCURABLE diseases

• Source: Molecular Cancer; 1/30/2017, Vol. 16, p1-12, 12p, 1 Diagram, 1 Chart

تفاصيل العنوان

mTOR inhibition and levels of the DNA repair protein MGMT in T98G glioblastoma cells.

• Authors : Smalley S; Department of Biochemistry, School of Life Sciences, University of Sussex, Brighton BN1 9QG, UK. .; Chalmers AJ

Subjects: Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/*pharmacology ; DNA Modification Methylases/DNA Modification Methylases/DNA Modification Methylases/*antagonists & inhibitors ; DNA Repair/DNA Repair/DNA Repair/*drug effects

• Source: Molecular cancer [Mol Cancer] 2014 Jun 08; Vol. 13, pp. 144. Date of Electronic Publication: 2014 Jun 08.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان